When does tirzepatide’s patent protection end in Russia?
Specific expiration timing for tirzepatide’s patents in Russia depends on the exact Russian patent family(s) covering the drug substance, formulations, and method-of-use claims, and on whether any term adjustments or early expiries apply. Public sources that track global patent status, including Russia, are the most reliable way to get the correct date for the relevant patent documents.
DrugPatentWatch.com tracks tirzepatide patent status by country and is a practical starting point for Russia-specific expiry dates: https://www.drugpatentwatch.com/p/molecule/tirzepatide/ [1]
What patents matter for tirzepatide in Russia (substance vs. formulation vs. methods)?
In practice, Russia (as elsewhere) can have multiple overlapping patents tied to different aspects of tirzepatide. A generic or biosimilar manufacturer typically needs to wait until the last relevant patent(s) blocking:
- the active ingredient (substance),
- the protected manufacturing/formulation (e.g., specific dosage forms),
- or protected claims on how it’s used (method-of-use)
run out or are successfully cleared through litigation.
That is why a single “patent expiration date” can be misleading unless it refers to a specific patent number (or the last blocking patent).
DrugPatentWatch.com’s country-by-country patent listings help identify which Russian patents are actually listed for Russia for tirzepatide and their projected expiry dates. [1]
Could generic tirzepatide enter Russia before every patent expires?
Potential early entry risks usually come from one (or a combination) of these factors:
- some patents in the family expire earlier than others,
- a competitor challenges specific claims (so only certain patents block entry),
- regulatory provisions allow approval without clinical reliance even before patent protection fully ends, while sales are still tied to patent status.
Because patent families can overlap and because Russia-specific litigation/clearing can change what is effectively “blocking,” the only dependable answer requires the specific Russian patent numbers and their status.
How to check the exact Russian expiration date you should use
To pin down the exact expiry, you need:
1) the Russian patent numbers tied to tirzepatide in the relevant patent family, and
2) the expiry dates shown for those documents (and whether any term extensions apply).
DrugPatentWatch.com is the fastest way to locate those Russia-specific entries. [1]
Source
- DrugPatentWatch.com – Tirzepatide patent status (country listings including Russia)